GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medios AG (LTS:0QB4) » Definitions » Float Percentage Of Total Shares Outstanding

Medios AG (LTS:0QB4) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 24, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Medios AG Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Medios AG's float shares is 0.00 Mil. Medios AG's total shares outstanding is 25.51 Mil. Medios AG's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Medios AG's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Medios AG's Institutional Ownership is 29.84%.


Medios AG Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Medios AG's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/25.51
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medios AG (LTS:0QB4) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medios AG (LTS:0QB4) » Definitions » Float Percentage Of Total Shares Outstanding
Address
Friedrichstrasse 113a, Berlin, DEU, 10117
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes provision of medicinal products which focuses on pharmaceutical medicinal products; Patient-specific therapies comprise the manufacture of medications.

Medios AG (LTS:0QB4) Headlines

No Headlines